Patents by Inventor Catherine Kaczorowski

Catherine Kaczorowski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TRPC3 AS A THERAPEUTIC TARGET FOR ALZHEIMER’S DISEASE
    Publication number: 20240099277
    Abstract: Provided herein, in some embodiments, are methods for modulating expression and/or activity of transient receptor potential cation channel subfamily C, member 3 (TRPC3), as well as methods of treating Alzheimer's disease.
    Type: Application
    Filed: June 15, 2023
    Publication date: March 28, 2024
    Applicant: The Jackson Laboratory
    Inventors: Catherine Kaczorowski, Sarah M. Neuner, Kristen M.S. O'Connell
  • TRANSIENT RECEPTOR POTENTIAL CANONICAL 3 INHIBITORS AND METHODS OF USE THEREOF
    Publication number: 20230265068
    Abstract: Provided herein are compounds, pharmaceutical compositions comprising such compounds, and methods of using such compounds to treat diseases or disorders associated with TRPC3 activity.
    Type: Application
    Filed: April 12, 2023
    Publication date: August 24, 2023
    Applicant: University of Tennessee Research Foundation
    Inventors: Wei Li, Julio Cordero-Morales, Jianxiong Jiang, Zhongzhi Wu, Francesca Liao, Catherine Kaczorowski
  • TRPC3 as a therapeutic target for alzheimer's disease
    Patent number: 11723347
    Abstract: Provided herein, in some embodiments, are methods for modulating expression and/or activity of transient receptor potential cation channel subfamily C, member 3 (TRPC3), as well as methods of treating Alzheimer's disease.
    Type: Grant
    Filed: November 19, 2019
    Date of Patent: August 15, 2023
    Assignee: The Jackson Laboratory
    Inventors: Catherine Kaczorowski, Sarah M. Neuner, Kristen M. S. O'Connell
  • DLGAP2 AS A THERAPEUTIC TARGET FOR AND ALZHEIMER'S DISEASE AND AGE-RELATED COGNITIVE DECLINE
    Publication number: 20210321594
    Abstract: Provided herein, in some embodiments, are methods for modulating expression and/or activity of disks large-associated protein 2 (DLGAP2), as well as methods of treating age-related cognitive decline, such as Alzheimer's disease.
    Type: Application
    Filed: April 30, 2021
    Publication date: October 21, 2021
    Applicant: The Jackson Laboratory
    Inventors: Catherine Kaczorowski, Sarah M. Neuner
  • TRPC3 AS A THERAPEUTIC TARGET FOR ALZHEIMER'S DISEASE
    Publication number: 20200154683
    Abstract: Provided herein, in some embodiments, are methods for modulating expression and/or activity of transient receptor potential cation channel subfamily C, member 3 (TRPC3), as well as methods of treating Alzheimer's disease.
    Type: Application
    Filed: November 19, 2019
    Publication date: May 21, 2020
    Applicant: The Jackson Laboratory
    Inventors: Catherine Kaczorowski, Sarah M. Neuner, Kristen M.S. O'Connell